Skip to main content
SpringerLink
Log in

Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry

  • Review
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

In 1951, we were pioneers in initiating screening of antitumor agents from microbial metabolites. We discovered bleomycin in 1962 and aclacinomycin in 1975. Peplomycin, a derivative of bleomycin, and pirarubicin, a tetrahydropyranyl derivative of doxorubicin, were also studied. All of them have been clinically used for the treatment of cancer. Using new screening methods, we isolated spergualin in 1982. This agent exhibited immunosuppressive activity as well as antitumor activity. Deoxyspergualin, a derivative of spergualin, is now clinically used for the treatment of acute rejection after kidney transplantation. Bestatin was screened as an inhibitor of aminopeptidase B in 1976. It binds to the aminopeptidases located on the cell membrane of immunocompetent cells and modulates immune responses. It is now used for the treatment of acute non-lymphocytic leukemia. Microbial metabolites will become more important as a source of anticancer drugs in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

BLM :

bleomycin

SCC :

squamous cell carcinoma

DNM :

daunorubicin

ACM :

aclacinomycin

DSG :

15-deoxyspergualin

References

  • Arcamone F, Cossinellie G, Fantini G, Grein A, Orezzi P, Pol C, Spalla C (1969) Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic fromS. peucetius var.caesius. Biotechnol Bioeng 11:1101–1110

    PubMed  Google Scholar 

  • Dantchev D, Slioussartchouk V, Paintrand M, Hayat M, Bourut C, Mathe G (1979) Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32 and aclacinomycin. Cancer Treat Rep 63:875–888

    PubMed  Google Scholar 

  • DiMarco H, Silvestrini R, Gaetani M, Soldati M, Orezzi P, Dasdia T, Scarpinato BM, Valentini L (1964) Daunomycin, a new antibiotic of the rhodomycin group. Nature 201:706–707

    PubMed  Google Scholar 

  • Ebihara K, Nishikawa K, Shibasaki C, Takahashi K, Matsuda A (1987) Antitumor activity of peplomycin against 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumors (in Japanese). Jpn J Antibiot 40:1566–1570

    PubMed  Google Scholar 

  • Fujii A, Takita T, Maeda K, Umezawa H (1973) New component of bleomycin. J Antibiot (Tokyo) 26:396–397

    Google Scholar 

  • Hori S, Shirai M, Hirano S, Oki T, Inui T, Tsukagoshi S, Ishizuka M, Takeuchi T, Umezawa H (1977) Antitumor activity of new anthracycline antibiotics, aclacinomycin A and its analogs, and their toxicity. Gann 68:685–690

    PubMed  Google Scholar 

  • Ikeda S, Ishihara K (1986) Randomized, controlled study of bestatin in the treatment of stage Ib and II malignant melanoma. Int J Immunother 2:73–79

    Google Scholar 

  • Ishizuka M, Iinuma H, Takeuchi T, Umezawa H (1972) Effect of diketocoriolin B on antibody formation. J Antibiot (Tokyo) 25:320–321

    Google Scholar 

  • Ishizuka M, Aoyagi T, Takeuchi T, Umezaawa H (1981) Activity of bestatin: enhancement of immune responses and antitumor effect. In: Umezawa H (ed) Small molecular immunomodifiers of microbial origin — fundamental and clinical studies of bestatin. Japan Scientific Societies Press, Tokyo/Pergamon Press, Oxford, pp 17–38

    Google Scholar 

  • Itoh O, Kuroiwa S, Atsumi S, Umezawa K, Takeuchi T, Hori M (1989) Induction by the guanosine analogue oxanosine of reversion toward the normal phenotype of K-ras-transformed rat kidney cells. Cancer Res 49:996–1000

    PubMed  Google Scholar 

  • Izumoto S, Arita N, Ushio Y, Hayakawa T, Ohinishi T, Taki T, Yamamoto H, Oku Y, Mogami H, Komeshima H (1988) Effect of MX2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumor in rats (in Japanese). Jpn J Cancer Chemother 15:1765–1769

    Google Scholar 

  • Kasai H, Naganawa H, Takita T, Umezawa H (1979) Chemistry of bleomycin. XXII. Interaction of bleomycin with nucleic acids, preferential binding to guanine base and electrostatic effect of the terminal amine. J Antibiot (Tokyo) 31:1316–1320

    Google Scholar 

  • Kawatsu M, Yamashita T, Osono M, Ishizuka M, Takeuchi T (1993a) T cell activation by conagenin in mice. J Antibiot (Tokyo) 46:1687–1691

    Google Scholar 

  • Kawatsu M, Yamashita T, Osono M, Masuda T, Ishizuka M, Takeuchi T (1993b) Effect of conagenin in tumor bearing mice. Antitumor activity, generation of effector cells and cytokine production. J Antibiot (Tokyo) 46:1692–1698

    Google Scholar 

  • Kawatsu M, Yamashita T, Ishizuka M, Takeuchi T (1994) Effec of conagenin on thrombocytopenia induced by antitumor agents in mice. J Antibiot (Tokyo) 47:1123–1129

    Google Scholar 

  • Koiso K, Niijima T (1981) Chemotherapy of advanced prostatic cancer with peplomycin. Prostate [Suppl] 1:103–110

    Google Scholar 

  • Komeshima N, Tsuruo T, Umezawa H (1988) Antitumor activity of new morpholino anthracyclines. J Antibiot (Tokyo) 41:548–553

    Google Scholar 

  • Kunimoto T, Hori M, Umezawa H (1973) Mechanism of action of diketocoriolin B. Biochim Biophys Acta 298:513–525

    PubMed  Google Scholar 

  • Matsuda A, Yoshioka O, Ebihara K, Ekimoto H, Yamashita T, Umezawa H (1978) The search of new bleomycin. In: Carter SK, Crooke ST, Umezawa H (eds) Bleomycin: current status and new development. Academic Press, New York, pp 299–310

    Google Scholar 

  • Nakanishi Y, Hata Y, Sato N, Kawamura A, Uenuma T, Hasegawa M, Miyakawa K, Nakamura T, Kawai M, Kawamoto K, Taneda M, Nishimura A, Kitayama J, Oku T, Kasai Y, Inoue K (1984) Anticancer effect of peplomycin on advanced recurrent breast cancer (in Japanese). Jpn J Cancer Chemother 11:1428–1433

    Google Scholar 

  • Nemoto K, Abe F, Nakamura T, Ishizuka M, Takeuchi T, Umezawa H (1987a) Blastogenic responses and the release of interleukins 1 and 2 by spleen cells obtained from rat skin allograft recipients administered with 15-deoxyspergualin. J Antibiot (Tokyo) 40:1062–1064

    Google Scholar 

  • Nemoto K, Hayashi F, Abe T, Nakamura T, Ishizuka M, Umezawa H (1987b) Immunosuppressive activities of 15-deoxyspergualin in animals. J Antibiot (Tokyo) 40:561–562

    Google Scholar 

  • Nemoto K, Hayashi F, Fujii H, Ito J, Nakamura T, Takeuchi T, Umezawa H (1987c) Effect of 15-deoxyspergualin of graft-v-host disease in mice. Transplant Proc 19:3985–3986

    PubMed  Google Scholar 

  • Nemoto K, Hayashi M, Sugawara Y, Ito J, Abe F, Takita T, Nakamura T, Takeuchi T (1987d) Biological activities of deoxyspergualin in autoimmune disease mice. J Antibiot (Tokyo) 40:1253–1259

    Google Scholar 

  • Nishikawa K, Shibasaki C, Takahashi K, Nakamura T, Takeuchi T, Umezawa H (1986) Antitumor activity of spergualin, a novel antitumor antibiotic. J Antibiot (Tokyo) 39:1461–1466

    Google Scholar 

  • Nishimura T, Muto K, Tanaka N (1978) Drug sensivity of an adriamycin-resistant mutant subline of mouse leukemia L5178Y cells. J Antibiot (Tokyo) 31:493–495

    Google Scholar 

  • Oki T, Matsuzawa Y, Yoshimoto A, Numata K, Kitamura T, Hori S, Takamatsu A, Umezawa H, Ishizuka M, Naganawa H, Suda H, Hamada M, Takeuchi T (1975) New antitumor antbiotics, aclacinomycin A and B. J Antibiot (Tokyo) 28:830–834

    Google Scholar 

  • Ota K, Kurita S, Yamada K, Masaoka T, Uzuka Y, Ogawa N (1986) Immunotherapy with bestatin for acute non-lymphocytic leukemia in adults. Cancer Immunol Immunother 23:5–10

    PubMed  Google Scholar 

  • Povirk LF, Hogan M, Dattagupta N (1979) Binding of bleomycin to DNA: intercalation of the bithiazole ring. Biochemistry 18:96–101

    PubMed  Google Scholar 

  • Povirk LF, Hogan M, Dattagupta N, Buechner M (1981) Copper(II) bleomycin and copper(II) phleomycin: comparative study of deoxyribonucleic acid binding. Biochemistry 20:665–671

    PubMed  Google Scholar 

  • Saito T, and 19 other authors (1986) Phase II study of (2″R)-4′-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Jpn J Cancer Chemother 13:1060–1069

    Google Scholar 

  • Sato H, Isono K, Nabetani K, Arai Y, Endo M, Ide H, Mitomi T, Makuuchi H, Taguchi G (1984) Effect of bestatin on primary tumor and prognosis in patient with esophageal carcinoma (in Japanese). J Jpn Soc Cancer Ther 19:2312–2326

    Google Scholar 

  • Shimada N, Yagisawa N, Naganawa H, Takita T, Hamada M, Takeuchi T, Umezawa H (1981) Oxanosine, a novel nucleoside fromActinomycetes. J Antibiot (Tokyo) 34:1216–1218

    Google Scholar 

  • Sugiura Y, Muraoka Y, Fujii A, Takita T, Umezawa H (1979) Chemistry of bleomycin. XXIV. Deamido bleomycin from viewpoint of metal coordination and oxygen activation. J Antibiot (Tokyo) 32:756–758

    Google Scholar 

  • Takahashi Y, Naganawa H, Takeuchi T, Umezawa H, Komiyama T, Oki T, Inui T (1977) The structure of baumycins A1, A2, B1, B2, C1 and C2. J Antibiot (Tokyo) 30:622–624

    Google Scholar 

  • Takeuchi T, Iinuma H, Iwanaga J, Takahashi S, Takita T, Umezawa H (1969) Coriolin, a new basidiomycetes antibiotic. J Antibiot (Tokyo) 22:215–217

    Google Scholar 

  • Takeuchi T, Iinuma H, Kunimoto S, Masuda T, Ishizuka M, Takeuchi M, Hamada M, Naganawa H, Kondo S, Umezawa H (1981) A new antitumor antibiotic spergualin: Isolation and antitumor activity. J Antibiot (Tokyo) 34:1619–1621

    Google Scholar 

  • Takita T, Muraoka Y, Nakatani T, Fujii A, Iitaka Y, Umezawa H (1978a) Chemistry of bleomycin. XXI. Metal-complex of bleomycin and its implication for the mechanism of bleomycin action. J Antibiot (Tokyo) 31:1073–1077

    Google Scholar 

  • Takita T, Muraoka Y, Nakatani T, Fujii A, Umezawa Y, Naganawa H, Umezawa H (1978b) Chemistry of bleomycin. XIX. Revised structures of bleomycin and phleomycin. J Antibiot (Tokyo) 31:801–804

    Google Scholar 

  • Umeda Y, Moriguchi M, Ikai K, Kuroda H, Nakamura T, Fujii A, Takeuchi T, Umezawa H (1987) Synthesis and antitumor activity of spergualin analogues. III. Novel method for synthesis of optically active 15-deoxyspergualin and 15-deoxy-11-O-methylspergualin. J Antibiot (Tokyo) 40:1316–1324

    Google Scholar 

  • Umezawa H (1981) Small molecular weight immunomodifiers produced by microorganisms: Their screening and discoveries, and the genetics of microbial secondary metabolites. In: Umezawa H (ed) Small molecular immunomodifiers of microbial origin — fundamental and clinical studies of bestatin. Japan Scientific Societies Press, Tokyo/Pergamon Press, Oxford, pp 1–16

    Google Scholar 

  • Umezawa H, Takeuchi T, Nitta K, Yamamoto T, Yamaoka S (1953) Sarkomycin, an antitumor substance produced byStreptomyces. J Antibiot (Tokyo) A6:101

    Google Scholar 

  • Umezawa H, Maeda K, Takeuchi T, Okami Y (1966) New antibiotics, bleomycin A and B. J Antibiot (Tokyo) 19:200–209

    Google Scholar 

  • Umezawa H, Ishizuka M, Hori S, Chimura H, Takeuchi T, Komai T (1968) The distribution of3H-bleomycin in mouse tissue. J Antibiot (Tokyo) 21:638–642

    Google Scholar 

  • Umezawa H, Takeuchi T, Hori S, Sawa T, Ishizuka M, Ichikawa T, Komai T (1972) Studies on the mechanism of antitumor effect of bleomycin on squamous cell carcinoma. J Antibiot (Tokyo) 25:409–420

    Google Scholar 

  • Umezawa H, Takahashi Y, Kinoshita N, Naganawa H, Masuda T, Ishizuka M, Tatsuta K, Takeuchi T (1979) Tetrahydropyranyl derivatives of daunomycin and Adriamycin. J Antibiot (Tokyo) 32:1082–1084

    Google Scholar 

  • Umezawa H, Kondo S, Iinuma H, Kunimoto S, Ikeda Y, Iwasawa M, Ikeda H, Takeuchi T (1981) Structure of an antitumor antibiotic, spergualin. J Antibiot (Tokyo) 34:1622–1624

    Google Scholar 

  • Umezawa H, Ishiuzka M, Takeuchi T (1985) Suppression of tissue graft rejection by spergualin. J Antibiot (Tokyo) 38:283–284

    Google Scholar 

  • Umezawa H, Imoto M, Sawa T, Isshiki K, Matsuda N, Uchida T, Iinuma H, Hamada M, Takeuchi T (1986) Studies on new epidermal growth factor-receptor kinase inhibitors erbstatin produced by MH435-hF3. J Antibiot (Tokyo) 39:170–173

    Google Scholar 

  • Umezawa H, Ishizuka M, Takeuchi T, Abe F, Shibuya K (1987a) Bestatin, a low molecular immunomodifier produced by micro-organisms. Dev Ind Microbiol 27:31–36

    Google Scholar 

  • Umezawa H, Nakajima S, Kawai H, Komeshima N, Yoshimoto H, Urata T, Odagawa A, Otsuki N, Tatsuta K, Otake N, Takeuchi T (1987b) New morpholino anthracyclines, MX, MX2 and MY5. J Antibiot (Tokyo) 40:1058–1061

    Google Scholar 

  • Yamashita T, Iijima M, Nakamura H, Isshiki K, Naganawa H, Hattori S, Hamada M, Ishizuka M, Takeuchi T, Iitaka Y (1991) Conagenin, a low molecular weight immunomodulator produced byStreptomyces roseosporus. J Antibiot (Tokyo) 44:557–559

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Microbial Chemistry, 3-14-23 Kamiosaki, Shinagawa-ku, 141, Tokyo, Japan

    Tomio Takeuchi

Authors
  1. Tomio Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Work dedicated to Dr. Haruo Sugano on the occasion of his 70th birthday. The material of this paper was essentially presented at The Tomizo Yoshida Memorial Symposium on Future Perspectives in Cancer Treatment, held commemorating the 20th Anniversary of the Cancer Chemotherapy Center, Tokyo, in April 1993

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takeuchi, T. Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry. J Cancer Res Clin Oncol 121, 505–510 (1995). https://doi.org/10.1007/BF01197761

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01197761

Key words

Search

Navigation